H.R. 1130, Chronic Kidney Disease Improvement in Research and Treatment Act of 2015.
Education related to the issue that ESRD patients have access to Medicare Advantage plans.
Survey and Certification of dialysis clinics.
Issues related to Medicare advantage risk adjustment and payments; Issues related to improvement of chronic disease.
H.R. 5506, the Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists and Treatment Demonstration Act.
H.R. 5659 Expanding Seniors Receiving Dialysis (ESRD) Choice Act of 2016.
H.R. 5942 - Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act.
Duration: April 1, 2015
to
April 1, 2017
General Issues: Medicare/Medicaid , Health Issues , Veterans
Spending: about $385,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2015: U.S. Senate, House of Representatives
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Sarah Hamlett Leg Dir, Rep. Thelma Drake; Rep. Ed Schrock
Meghan Johnson Chief of Staff, Rep. Linda Sanchez
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2017
Federal City Strategies terminated an engagement in which they represented DaVita Inc. on July 24, 2017.
Original Filing: 300898390.xml
1st Quarter, 2017
In Q1, Federal City Strategies did no lobbying for DaVita Inc. . The report was filed on April 25, 2017.
Original Filing: 300879172.xml
4th Quarter, 2016
In Q4, Federal City Strategies lobbied for DaVita Inc. , earning $50,000. The report was filed on Jan. 22, 2017.
Original Filing: 300854209.xml
Lobbying Issues
H.R. 1130, Chronic Kidney Disease Improvement in Research and Treatment Act of 2015.
Education related to the issue that ESRD patients have access to Medicare Advantage plans.
Survey and Certification of dialysis clinics.
Issues related to Medicare advantage risk adjustment and payments; Issues related to improvement of chronic disease.
H.R. 5506, the Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists and Treatment Demonstration Act.
H.R. 5659 Expanding Seniors Receiving Dialysis (ESRD) Choice Act of 2016.
H.R. 5942 - Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Medicare/Medicaid
3rd Quarter, 2016
In Q3, Federal City Strategies lobbied for DaVita Inc. , earning $50,000. The report was filed on Oct. 22, 2016.
Original Filing: 300840477.xml
Lobbying Issues
H.R. 1130, Chronic Kidney Disease Improvement in Research and Treatment Act of 2015.
Education related to the issue that ESRD patients have access to Medicare Advantage plans.
Survey and Certification of dialysis clinics.
Issues related to Medicare advantage risk adjustment and payments; Issues related to improvement of chronic disease.
H.R. 5506, the Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists and Treatment Demonstration Act.
H.R. 5659 Expanding Seniors Receiving Dialysis (ESRD) Choice Act of 2016.
H.R. 5942 - Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services Demonstration Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Medicare/Medicaid
2nd Quarter, 2016
In Q2, Federal City Strategies lobbied for DaVita Healthcare Partners, Inc. , earning $50,000. The report was filed on July 21, 2016.
Original Filing: 300822200.xml
Lobbying Issues
H.R. 1130, Chronic Kidney Disease Improvement in Research and Treatment Act of 2015.
Education related to the issue that ESRD patients have access to Medicare Advantage plans.
Survey and Certification of dialysis clinics.
ESRD integrated care demonstration project proposal.
Agencies Lobbied
U.S. Senate
Type of Issue
Medicare/Medicaid
1st Quarter, 2016
In Q1, Federal City Strategies lobbied for DaVita Healthcare Partners, Inc. , earning $50,000. The report was filed on April 19, 2016.
Original Filing: 300797039.xml
Lobbying Issues
Healthcare reimbursement and risk adjustment policy.
H.R. 1130, Chronic Kidney Disease Improvement in Research and Treatment Act of 2015.
Medicare payment for End Stage Renal Disease (ESRD).
Education related to the issue that ESRD patients have access to Medicare Advantage plans.
Survey and Certification of dialysis clinics.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Veterans access to dialysis services.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Healthcare reimbursement and risk adjustment policy.
H.R. 1130, Chronic Kidney Disease Improvement in Research and Treatment Act of 2015.
Medicare payment for End Stage Renal Disease (ESRD).
Education related to the issue that ESRD patients have access to Medicare Advantage plans.
Work on potential legislation to support better integration of care for ESRD patients.
Survey and certification of dialysis clinics.
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, Federal City Strategies lobbied for DaVita Healthcare Partners, Inc. , earning $45,000. The report was filed on Jan. 20, 2016.
Original Filing: 300780692.xml
Lobbying Issues
Healthcare reimbursement policy.
H.R. 1130, Chronic Kidney Disease Improvement in Research and Treatment Act of 2015.
Medicare payment for End Stage Renal Disease (ESRD).
Education related to the issue that ESRD patients have access to Medicare Advantage plans.
H.R. 2029; PL 114-113- Consolidated Appropriations Act of of FY 2016.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Veterans access to dialysis services.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Healthcare reimbursement policy.
H.R. 1130, Chronic Kidney Disease Improvement in Research and Treatment Act of 2015.
Medicare payment for End Stage Renal Disease (ESRD).
Education related to the issue that ESRD patients have access to Medicare Advantage plans.
Work on potential legislation to support better integration of care for ESRD patients.
H.R. 2029; PL 114-113- Consolidated Appropriations Act of of FY 2016.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, Federal City Strategies lobbied for DaVita Healthcare Partners, Inc. , earning $45,000. The report was filed on Oct. 27, 2015.
Original Filing: 300766661.xml
Lobbying Issues
Healthcare reimbursement policy.
H.R. 1130, Chronic Kidney Disease Improvement in Research and Treatment Act of 2015.
Medicare payment for End Stage Renal Disease (ESRD).
Education related to the issue that ESRD patients have access to Medicare Advantage plans.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Veterans access to dialysis services.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Healthcare reimbursement policy.
H.R. 1130, Chronic Kidney Disease Improvement in Research and Treatment Act of 2015.
Medicare payment for End Stage Renal Disease (ESRD).
Education related to the issue that ESRD patients have access to Medicare Advantage plans.
Work on potential legislation to support better integration of care for ESRD patients.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, Federal City Strategies lobbied for DaVita Healthcare Partners, Inc. , earning $45,000. The report was filed on July 20, 2015.
Original Filing: 300746763.xml
Lobbying Issues
Healthcare reimbursement policy.
H.R. 1130, Chronic Kidney Disease Improvement in Research and Treatment Act of 2015.
H.R. 2579, Securing Care for Seniors Act of 2015.
H.R. 2 - The Medicare Access and CHIP Reauthorization Act - work to include language to ensure that the Medicare Advantage Risk Adjustment Factor supported plans that covered vulnerable beneficiaries with multiple chronic conditions fairly.
Regulations and guidance related to the issue of risk adjustment for Medicare Advantage plans to ensure that vulnerable beneficiaries with chronic conditions have access to Medicare Advantage plans.
Regulations pertaining to reimbursement rates for ESRD-related services.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Veterans access to dialysis services.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Healthcare reimbursement policy.
H.R. 1130, Chronic Kidney Disease Improvement in Research and Treatment Act of 2015.
H.R. 2579, Securing Care for Seniors Act of 2015.
Regulations pertaining to reimbursement rates for ESRD-related services.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
Federal City Strategies filed a lobbying registration on April 22, 2015 to represent DaVita Healthcare Partners, Inc., effective April 1, 2015.
Original Filing: 300728584.xml
Issue(s) they said they’d lobby about: Issues related to Medicare reimbursement and the dialysis "bundle"; Medicare Advantage; chronic care, and specifically CKD; changes to Medicare Part C and D; and veterans' dialysis services. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...